Awareness and Adherence in Young and Older Glaucoma Patients who Live in European Side of İstanbul
PDF
Cite
Share
Request
Research
P: 357-361
December 2019

Awareness and Adherence in Young and Older Glaucoma Patients who Live in European Side of İstanbul

Med J Bakirkoy 2019;15(4):357-361
1. Sağlık Bilimleri Üniversitesi Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Göz Hastalıkları Kliniği, İstanbul, Türkiye
2. Memorial Şişli Hastanesi, Göz Hastalıkları Kliniği, İstanbul, Türkiye
No information available.
No information available
Received Date: 25.10.2018
Accepted Date: 15.10.2019
Publish Date: 20.12.2019
PDF
Cite
Share
Request

ABSTRACT

Objective:

We aimed to compare the demographics, awareness about glaucoma, and adherence to the treatment between the young and old population of primary open angle glaucoma (POAG) patients.

Methods:

The POAG patients who were under follow-up in Bakırköy Training and Research Hospital Ophthalmology Clinic and were using medication since at least one year and volunteered for our survey were included this cross-sectional study between April and May 2018. Two surveys which included 13 questions and were used in previous studies were enriched with 6 additional questions and applied to the patients. The patients were divided into two groups according to the World Health Organization’s classification in regard to age as ≤65 years (young patients) and >65 years (old patients) and compared in regards to the survey questions.

Results:

There was not statistically significant between the two groups in regards to gender, general awareness about glaucoma, regular follow-up, regular drug use, family history of glaucoma, disability in hand and arm movements, duration of glaucoma (p>0.05 for all). There was a statistical difference between the two groups in regards to the education level (the patients ≤65 years were more educated, p=0.03), awareness of blindness secondary to the disease (more frequent in the patients ≤65 years old, p=0.02), awareness of drug’s brand (more frequent in the patients ≤65 years old, p=0.003), requiring assistance while using the drugs (more frequent in the group of patients >65 years-old, p=0.01), monthly number of forgetting the drug doses (more frequent in the group of patients >65 years-old, p=0.006), living alone (more frequent in the group of patients >65 years-old, p=0.02), and the number of used drugs (more frequent in the group of patients >65 years-old, p=0.03).

Conclusion:

It is obvious that the patients who are >65 years old will be less adherent to glaucoma treatment as they more frequently require assistance for drug use and live alone.

Keywords: Glaucoma, drug, adherence

References

1
Yüzbaşıoğlu E, Tuğcu B, Yıldırım H, Karahasanoğlu A, Yirik G. Topikal Glokom Tedavisinin Oküler Kan Akımı Üzerine Etkileri. Bakırköy Tıp Dergisi 2008;4:111-4.
2
Cankaya AB. Glokom Tedavisine Uyum ve Bağlılık. Glo-Kat 2010;5:127-33.
3
Doğanay S, Çankaya C. Glokom İlaçlarının Gelişimi ve İlaç Tedavi Prensipleri. Glo-Kat 2010;5:179-85.
4
Alkin Z, Satana B, Ozkaya A, Basarir B, Altan C, Yazici AT, et al. Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study. Biomed Res Int 2014;2014:469163.
5
Şimşek A, Bilgin B, Bilak Ş, Karadağ AS. Glokom Hastalarının Tedaviye Olan Uyum ve Farkındalığında Eğitim Düzeyinin Önemi. Turkiye Klinikleri J Ophthalmol 2016;25:78-82.
6
Çankaya AB, İşlek E, Şimşek T, Özdamar Y, Zilelioğlu O. Glokom Hastalarının Tedaviye Uyum ve Bağlılıklarını Etkileyen Faktörlerin İncelenmesi. Turk J Ophthalmol 2010;40:199-204.
7
Eren MH, Altan Ç, Akagündüz U, Bayraktar Ş, Yılmaz ÖF. Glokomun Medikal Tedavisinde Hasta Uyumu. Glo-Kat 2008;3:158-64.
8
Robin A, Grover DS. Compliance and adherence in glaucoma management. Indian J Ophthalmol 2011;59 Suppl 1:S93-6.
9
Dreer LE, Girkin C, Mansberger SL. Determinants of Medication Adherence to Topical Glaucoma Therapy. J Glaucoma 2012;21:234–40.
10
Cate H, Bhattacharya D, Clark A, Holland R, Broadway DC. Patterns of adherence behaviour for patients with glaucoma. Eye (Lond) 2013;27:545-53.
11
Gatwwod JD, Johnson J, Jerkins B. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study. J Glaucoma 2017;26:1056-61.
12
Atey TM, Shibeshi W, Giorgis AT, Asgedom SW. The Impact of Adherence and Instillation Proficiency of Topical Glaucoma Medications on Intraocular Pressure. J Ophthalmol 2017;2017:1683430.
13
Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol 2016;16:131.
14
Loon SC, Jin J, Jin Goh M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J Glaucoma 2015;24:e36-42.
15
Olthoff CM, Hoevenaars JG, van den Borne BW, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2009;247:235-43.
16
Rees G, Leong O, Crowston JG, Lamoureux EL. Intentional and unintentional non adherence to ocular hypotensive treatment in patients with glaucoma. Ophthalmology 2010;117:903-8.
17
Vélez-Gómez MC, Vásquez-Trespalacios EM. Adherence to topical treatment of glaucoma, risk and protective factors: A review. Arch Soc Esp Oftalmol 2018;93:87-92.
18
Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol 2008;53 Suppl1:S57-68.
2024 ©️ Galenos Publishing House